A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Completed · Phase 3 · Has a placebo group

Conditions studied: Iron Deficiency Anemia

In brief

To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

Key facts

Study ID
NCT01114139
Run by
AMAG Pharmaceuticals, Inc.
People needed
812
Starts
2010-06-19
Expected to finish
2012-10-22
Last updated by the study team
2022-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.